Susan J Ward

Susan J Ward is the Founder and Executive Director of cTAP-duchenne, a role that leverages her extensive experience in the pharmaceutical and biotech industries.1 With a background spanning over a decade in senior and executive-level management positions, Ward has established herself as a seasoned professional in her field.

Professional Background

Ward's career is marked by significant contributions to the pharmaceutical and biotechnology sectors. She is known for being an impactful and effective colleague, with strong communication skills that have likely contributed to her success in leadership roles.1

Academic and Research Achievements

Susan J Ward's credentials are impressive:

• She earned her Ph.D. from the University of Manchester in the UK.3
• Her research output is substantial, having authored over 60 articles in peer-reviewed journals.3
• Ward is also an innovator, holding 9 patents to her name.3

Current Role

As the Founder and Executive Director of cTAP-duchenne, Ward is likely applying her extensive industry knowledge and research experience to advance the organization's goals. While the specific focus of cTAP-duchenne is not detailed in the provided information, the name suggests it may be related to Duchenne muscular dystrophy research or patient advocacy.

Personal Insights

Interestingly, Ward has shared that she is an ex-pat who has been living and voting in the United States for decades. Despite this, she has expressed admiration for certain aspects of the British monarchy, indicating a nuanced perspective on her heritage and adopted home.2

Susan J Ward's LinkedIn profile (username: susanjward) likely provides more detailed information about her professional journey and current work with cTAP-duchenne.